Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris. Future Microbiol. 2019 Sep;14(14):1235-1242. [6]. Bunick CG, et al. Antibacterial Mechanisms and Efficacy of Sarecycline in Animal Models of Infection and Inflammation. Antibiotics (Basel). ...
分子式C24H29N3O8分子量487.51 纯度98%配送惯例下常温包邮 产品描述Sarecycline, also known as WC-3035 and P005672, is a novel, tetracycline-derived, narrow-spectrum antibiotic being developed for use as an oral once daily antibiotic treatment for patients suffering from moderate to severe acne vul...
[4] ZHANEL G, CRITCHLEY I, LIN L Y, et al.Microbiological profile of sarecycline:a novel targeted spectrum tetracycline for the treatment of acne vulgaris[J].Antimicrob Agents Chemother, 2018, 63 (1) :e01297-18. [5] US FDA.Highlights of prescribing information[EB/OL].[2018-10-01]. ...
Sarecycline is a prescription medication used for the treatment ofAcne vulgaris. Sarecycline is available under the following different brand names: Seysara What Are Side Effects Associated with Using Sarecycline? Common side effects of Sarecycline include: nausea and vaginalyeastinfections Serious si...
治疗类别 Anti-Acne Preparations;Anti-Acne Preparations for Systemic Use;Anti-Bacterial Agents;Antibacterials for Systemic Use;Antiinfectives for Systemic Use;P-glycoprotein/ABCB1 Inhibitors;Tetracyclines UNII号 94O110CX2E CAS号 1035654-66-0 分子量 487.509 分子式 C24H29N3O8 适应症 Sarecycl...
Sarecycline (trade name Seysara; development code WC-3035) is a tetracycline-derived antibiotic. In the United States, it was approved by the FDA in October 2018 for the treatment of moderate to severe acne vulgaris.[1]Paratek Pharmaceuticals, Inc. licensed the US rights to sarecycline for ...
[2]. Moore AY, Charles JEM, Moore S. Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris. Future Microbiol. 2019;14(14):1235-1242. [3]. Batool Z, et al. Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome. ...
描述 Sarecycline hydrochloride (Sarecycline HCl) is an orally active narrow-spectrum tetracycline antibiotic with antimicrobial and anti-inflammatory activity, inhibits Acinetobacter and Candida tropicalis, and can be used to treat inflammatory acne. 体外活性 方法:为了评估 Sarecycline hydrochloride 及其对...
Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris. Future Microbiol. 2019;14(14):1235-1242.Batool Z, et al. Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome. Proc Natl Acad Sci U S A. 2020;117(34):20530-...
Introduction: Sarecycline is a novel, narrow-spectrum, tetracycline-derived antibiotic approved in the US for the treatment of moderate-to-severe acne vulgaris in patients aged ≥9 years [1, 2]. Objectives: To evaluate the efficacy and safety of sarecycline in Chinese patients with moderate-to...